Viking Therapeutics Non-Current Deferred Revenue (Quarterly) Analysis

Viking Therapeutics, Inc. (VKTX)

31.56 -0.43 (-1.34%) USD | NASDAQ | Jan 12, 12:08

View Non-Current Deferred Revenue (Quarterly) for VKTX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Revenue (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Revenue (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Revenue (Quarterly) Benchmarks

Start Trial